Fundraising

CAR-T cell therapy
#CAR-T #Cell therapy #Financing #Fundraising #Haematology #March Biosciences #Oncology

March Bio raises $28.4m for autologous CAR-T therapy

Biotechnology company March Biosciences (March Bio) has announced the close of a $28.4 million oversubscribed Series A financing, having raised over $51 million to date. Mission BioCapital and 4BIO Capital led the financing, with participation from KdT Ventures, Alexandria Venture Investments, Volnay Therapeutics, Modi Ventures, and… Read More

#Business & Investment #News

#Arsenal Biosciences #Cell therapy #Fundraising #Oncology #Solid tumours

Cell therapy developer ArsenalBio raises $325 million

Arsenal Biosciences has closed an oversubscribed $325 million Series C financing round to support its development of CAR T-cell therapies for solid tumours. The funding round included new investors ARCH Venture Partners, Milky Way Investments Group, Regeneron Ventures, NVentures (NVIDIA’s venture capital arm), Luma Group, funds… Read More

#Business & Investment #News

Dorte Gram
#Fundraising #GLP-1 #Novo Nordisk #Obesity #Pila Pharma #Weight loss

Scientist who discovered Ozempic to study new obesity drug

Dorte Gram, founder of Pila Pharma and a former Novo Nordisk researcher who identified the molecule that became semaglutide, the active ingredient in Ozempic and Wegovy, has raised 10 million SEK ($980,320) for a novel obesity-related study. The money will allow the company to study drug… Read More

#News

#Antivirals #Dermatology #Fundraising #ILC Therapeutics #Infectious diseases

ILC Therapeutics raises £2.5m to develop hybrid interferons

Glasgow, UK-based ILC Therapeutics has successfully completed a fundraise of £2.5 ($3.2) million. The company develops hybrid interferons, a new drug class engineered for improved therapeutic profiles across multiple indications. The money will support the continued pre-clinical development of the company’s two lead assets,… Read More

#Business & Investment #News

#Draupnir Bio #Financing #Fundraising #Protein degradation

€12 million raised for extracellular protein degradation research

Biotechnology company Draupnir Bio has received equity investments totalling €12 million to support the company’s work in the field of targeted protein degradation (TPD). TPD is a rapidly emerging field in drug development, exploiting a cell’s own destruction machinery to tackle disease-causing proteins that have historically… Read More

#Business & Investment #News

#Element Biosciences #Fundraising #Gene sequencing #Investment #Multi-omics

Element Biosciences raises over $277 million

Element Biosciences has announced over $277 million in Series D investment to support continued development of its DNA sequencing and multi-omics technologies. The oversubscribed round was led by Wellington Management with participation from new and existing investors, including Samsung Electronics, Fidelity, Foresite Capital, funds and accounts… Read More

#Business & Investment #News

Wear a hat day
#Brain #Cancer research #Charity #Drug discovery #Fundraising #Oncology

Wear a hat for brain tumour research

Today is #WearAHatDay created by Brain Tumour Research to raise awareness and funds for research into finding treatments for brain cancer. Brain Tumour Research encourages people to “look super for science and help research breakthroughs happen”. Over the last ten years, Wear A Hat Day events have raised more than… Read More

#News

Scientist looking through microscope
#AI / data analytics / healthtech / informatics #Artificial intelligence (AI) #Automation / robotics #Financing #Fundraising #Iktos #Investment

AI and robotics drug discovery company raises €15.5M

Iktos has raised €15.5m in a Series A funding round to expand its artificial intelligence-based drug discovery technologies and solutions. The round was co-led by new investors M Ventures and Debiopharm Innovation Fund with participation from Omnes Capital. The financing will enable the company… Read More

#Business & Investment #News

London Marathon
#Charity #Fundraising #SPT Labtech

Support Carey Rooks’ marathon fundraising

Carey Rooks, Head of Brand and Communications at SPT Labtech, will be running the London Marathon on April 23, 2023 to raise money for Sue Ryder. “Why, oh why?! so many people ask us when we tell them we’re taking part in the London Marathon,” she… Read More

#News

UK on global map
#BioIndustry Association #Biologics / Biotechnology #Equity finance #Finance #Fundraising #Investment #Life sciences #Market reporting #Private investment #Seed funding #UK

UK remains strongest biotech hub in Europe despite general decline

After a disappointing start to the year, the last few months have seen a boost to fundraising for UK biotech companies. DDW’s Diana Spencer unpacks the Q3 figures and annual predictions from the BioIndustry Association1.  While 2021 was the highest year on record for… Read More

#Business & Investment #Exclusive Content #Market Reports

Ice Bucket Challenge
#ALS #Drug discovery #FDA #Fundraising #Ice Bucket Challenge #The ALS Association

‘Ice Bucket Challenge’ funds FDA-approved ALS treatment

The US Food and Drug Administration (FDA) has granted approval to AMX0035, a new treatment for people living with amyotrophic lateral sclerosis (ALS). Development of the drug was funded by $2.2 million from the ALS Association, raised by the 2014 social media craze the ‘Ice Bucket Challenge’. Another… Read More

#News #Regulatory #Trending News